Trial intelligence / Profile preview

Frozen Shoulder Treatment with IA Corticosteroid Injection and Suprascapular Nerve Block

2024-513057-78-00Phase 4Authorised

Sponsor
UZ Brussel
Start
Sep 2024
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 4 trial of methylprednisolone, lidocaine and ropivacaine in adhesive capsulitis (AC) (4 arms), sponsored by UZ Brussel. Primary endpoint: Change in SPADI score at 3 months. Planned start Sep 2024; status: authorised.

02

Drugs

methylprednisolonelidocaineropivacaine
03

Conditions

adhesive capsulitis (AC)

Beyond the preview

Go deeper on 2024-513057-78-00.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2024-513057-78-00.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call